Skip to main content
logo
Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
9.30
+0.06 (0.65%)
Aug 27, 2026, 12:30 PM EDT - Market open

Advanced Biomed Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
5.28-3.26-2.78-3.73-4.03-1.84
Depreciation & Amortization
0.320.340.40.230.110.06
Other Amortization
---0.140.01-
Loss (Gain) From Sale of Assets
-7.35--0.150.04-
Asset Writedown & Restructuring Costs
----1.62-
Change in Accounts Payable
1.76-0.120.480.380.910.02
Change in Other Net Operating Assets
0.11-2.79-0.22-0.130.591.29
Operating Cash Flow
-2.91-5.83-2.13-2.96-0.74-0.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-0.04-0.03-0.07-0.21-0.89-0.03
Sale of Property, Plant & Equipment
----0.03-
Cash Acquisitions
----0.2-
Divestitures
----0.05--
Sale (Purchase) of Intangibles
----0-0.42-
Investing Cash Flow
-0.04-0.03-0.07-0.26-1.08-0.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
-0.30.29---
Long-Term Debt Issued
-0.981.66---
Total Debt Issued
0.661.281.95---
Short-Term Debt Repaid
--0.24----
Long-Term Debt Repaid
--0.6----
Total Debt Repaid
-0.84-0.84----
Net Debt Issued (Repaid)
-0.180.441.95---
Issuance of Common Stock
0.145.49-1.016.10.7
Other Financing Activities
0.31--0.09-0.55--
Financing Cash Flow
0.275.931.870.466.10.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
0.10.220.320.610.45-0.2
Net Cash Flow
-2.580.3-0.01-2.164.720

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-2.94-5.86-2.2-3.17-1.63-0.5
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.60-5.71-2.20-3.19-2.30-0.87
Levered Free Cash Flow
-8.49-4.38-2.72-1.40.69-
Unlevered Free Cash Flow
-8.49-4.38-2.72-1.40.69-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Change in Working Capital
1.87-2.910.260.251.51.31
SEC Filings: 10-K · 10-Q